- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Biopharmaceutical and Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Biopharmaceutical and Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pharmaceuticals Industry accounting for % of the Biopharmaceutical and Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Biopharmaceutical segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Biopharmaceutical and Vaccines include Novartis, Pfizer, Sanofi, Roche, and Abbott, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biopharmaceutical and Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Biopharmaceutical
Vaccine Production
Market segment by Application, can be divided into
Pharmaceuticals Industry
Clinical Diagnosis
Scientific Research
Others
Market segment by players, this report covers
Novartis
Pfizer
Sanofi
Roche
Abbott
Biogen Idec
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline
Merck
Lonza
Boehringer Ingelheim
Rentschler
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biopharmaceutical and Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biopharmaceutical and Vaccines, with revenue, gross margin and global market share of Biopharmaceutical and Vaccines from 2019 to 2022.
Chapter 3, the Biopharmaceutical and Vaccines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biopharmaceutical and Vaccines market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biopharmaceutical and Vaccines research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Biopharmaceutical and Vaccines
1.2 Classification of Biopharmaceutical and Vaccines by Type
1.2.1 Overview: Global Biopharmaceutical and Vaccines Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Biopharmaceutical and Vaccines Revenue Market Share by Type in 2021
1.2.3 Biopharmaceutical
1.2.4 Vaccine Production
1.3 Global Biopharmaceutical and Vaccines Market by Application
1.3.1 Overview: Global Biopharmaceutical and Vaccines Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pharmaceuticals Industry
1.3.3 Clinical Diagnosis
1.3.4 Scientific Research
1.3.5 Others
1.4 Global Biopharmaceutical and Vaccines Market Size & Forecast
1.5 Global Biopharmaceutical and Vaccines Market Size and Forecast by Region
1.5.1 Global Biopharmaceutical and Vaccines Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Biopharmaceutical and Vaccines Market Size by Region, (2017-2022)
1.5.3 North America Biopharmaceutical and Vaccines Market Size and Prospect (2017-2028)
1.5.4 Europe Biopharmaceutical and Vaccines Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Biopharmaceutical and Vaccines Market Size and Prospect (2017-2028)
1.5.6 South America Biopharmaceutical and Vaccines Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Biopharmaceutical and Vaccines Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biopharmaceutical and Vaccines Market Drivers
1.6.2 Biopharmaceutical and Vaccines Market Restraints
1.6.3 Biopharmaceutical and Vaccines Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Biopharmaceutical and Vaccines Product and Solutions
2.1.4 Novartis Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Biopharmaceutical and Vaccines Product and Solutions
2.2.4 Pfizer Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Biopharmaceutical and Vaccines Product and Solutions
2.3.4 Sanofi Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Biopharmaceutical and Vaccines Product and Solutions
2.4.4 Roche Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Roche Recent Developments and Future Plans
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Biopharmaceutical and Vaccines Product and Solutions
2.5.4 Abbott Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Abbott Recent Developments and Future Plans
2.6 Biogen Idec
2.6.1 Biogen Idec Details
2.6.2 Biogen Idec Major Business
2.6.3 Biogen Idec Biopharmaceutical and Vaccines Product and Solutions
2.6.4 Biogen Idec Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Biogen Idec Recent Developments and Future Plans
2.7 Regeneron Pharmaceuticals
2.7.1 Regeneron Pharmaceuticals Details
2.7.2 Regeneron Pharmaceuticals Major Business
2.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product and Solutions
2.7.4 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
2.8 Alexion Pharmaceuticals
2.8.1 Alexion Pharmaceuticals Details
2.8.2 Alexion Pharmaceuticals Major Business
2.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product and Solutions
2.8.4 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Alexion Pharmaceuticals Recent Developments and Future Plans
2.9 Johnson and Johnson
2.9.1 Johnson and Johnson Details
2.9.2 Johnson and Johnson Major Business
2.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Product and Solutions
2.9.4 Johnson and Johnson Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Johnson and Johnson Recent Developments and Future Plans
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business
2.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Product and Solutions
2.10.4 GlaxoSmithKline Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 GlaxoSmithKline Recent Developments and Future Plans
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business
2.11.3 Merck Biopharmaceutical and Vaccines Product and Solutions
2.11.4 Merck Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Merck Recent Developments and Future Plans
2.12 Lonza
2.12.1 Lonza Details
2.12.2 Lonza Major Business
2.12.3 Lonza Biopharmaceutical and Vaccines Product and Solutions
2.12.4 Lonza Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Lonza Recent Developments and Future Plans
2.13 Boehringer Ingelheim
2.13.1 Boehringer Ingelheim Details
2.13.2 Boehringer Ingelheim Major Business
2.13.3 Boehringer Ingelheim Biopharmaceutical and Vaccines Product and Solutions
2.13.4 Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Boehringer Ingelheim Recent Developments and Future Plans
2.14 Rentschler
2.14.1 Rentschler Details
2.14.2 Rentschler Major Business
2.14.3 Rentschler Biopharmaceutical and Vaccines Product and Solutions
2.14.4 Rentschler Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Rentschler Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Biopharmaceutical and Vaccines Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Biopharmaceutical and Vaccines Players Market Share in 2021
3.2.2 Top 10 Biopharmaceutical and Vaccines Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Biopharmaceutical and Vaccines Players Head Office, Products and Services Provided
3.4 Biopharmaceutical and Vaccines Mergers & Acquisitions
3.5 Biopharmaceutical and Vaccines New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Biopharmaceutical and Vaccines Revenue and Market Share by Type (2017-2022)
4.2 Global Biopharmaceutical and Vaccines Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Biopharmaceutical and Vaccines Revenue Market Share by Application (2017-2022)
5.2 Global Biopharmaceutical and Vaccines Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Biopharmaceutical and Vaccines Revenue by Type (2017-2028)
6.2 North America Biopharmaceutical and Vaccines Revenue by Application (2017-2028)
6.3 North America Biopharmaceutical and Vaccines Market Size by Country
6.3.1 North America Biopharmaceutical and Vaccines Revenue by Country (2017-2028)
6.3.2 United States Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
6.3.3 Canada Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
6.3.4 Mexico Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Biopharmaceutical and Vaccines Revenue by Type (2017-2028)
7.2 Europe Biopharmaceutical and Vaccines Revenue by Application (2017-2028)
7.3 Europe Biopharmaceutical and Vaccines Market Size by Country
7.3.1 Europe Biopharmaceutical and Vaccines Revenue by Country (2017-2028)
7.3.2 Germany Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
7.3.3 France Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
7.3.5 Russia Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
7.3.6 Italy Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biopharmaceutical and Vaccines Revenue by Type (2017-2028)
8.2 Asia-Pacific Biopharmaceutical and Vaccines Revenue by Application (2017-2028)
8.3 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region
8.3.1 Asia-Pacific Biopharmaceutical and Vaccines Revenue by Region (2017-2028)
8.3.2 China Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
8.3.3 Japan Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
8.3.4 South Korea Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
8.3.5 India Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
8.3.7 Australia Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Biopharmaceutical and Vaccines Revenue by Type (2017-2028)
9.2 South America Biopharmaceutical and Vaccines Revenue by Application (2017-2028)
9.3 South America Biopharmaceutical and Vaccines Market Size by Country
9.3.1 South America Biopharmaceutical and Vaccines Revenue by Country (2017-2028)
9.3.2 Brazil Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
9.3.3 Argentina Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biopharmaceutical and Vaccines Revenue by Type (2017-2028)
10.2 Middle East & Africa Biopharmaceutical and Vaccines Revenue by Application (2017-2028)
10.3 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country
10.3.1 Middle East & Africa Biopharmaceutical and Vaccines Revenue by Country (2017-2028)
10.3.2 Turkey Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
10.3.4 UAE Biopharmaceutical and Vaccines Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Biopharmaceutical and Vaccines Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Biopharmaceutical and Vaccines Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Biopharmaceutical and Vaccines Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Biopharmaceutical and Vaccines Revenue (USD Million) by Region (2017-2022)
Table 5. Global Biopharmaceutical and Vaccines Revenue Market Share by Region (2023-2028)
Table 6. Novartis Corporate Information, Head Office, and Major Competitors
Table 7. Novartis Major Business
Table 8. Novartis Biopharmaceutical and Vaccines Product and Solutions
Table 9. Novartis Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Biopharmaceutical and Vaccines Product and Solutions
Table 13. Pfizer Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Sanofi Corporate Information, Head Office, and Major Competitors
Table 15. Sanofi Major Business
Table 16. Sanofi Biopharmaceutical and Vaccines Product and Solutions
Table 17. Sanofi Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Biopharmaceutical and Vaccines Product and Solutions
Table 21. Roche Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Abbott Corporate Information, Head Office, and Major Competitors
Table 23. Abbott Major Business
Table 24. Abbott Biopharmaceutical and Vaccines Product and Solutions
Table 25. Abbott Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Biogen Idec Corporate Information, Head Office, and Major Competitors
Table 27. Biogen Idec Major Business
Table 28. Biogen Idec Biopharmaceutical and Vaccines Product and Solutions
Table 29. Biogen Idec Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Regeneron Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 31. Regeneron Pharmaceuticals Major Business
Table 32. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product and Solutions
Table 33. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Alexion Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 35. Alexion Pharmaceuticals Major Business
Table 36. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product and Solutions
Table 37. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Johnson and Johnson Corporate Information, Head Office, and Major Competitors
Table 39. Johnson and Johnson Major Business
Table 40. Johnson and Johnson Biopharmaceutical and Vaccines Product and Solutions
Table 41. Johnson and Johnson Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 43. GlaxoSmithKline Major Business
Table 44. GlaxoSmithKline Biopharmaceutical and Vaccines Product and Solutions
Table 45. GlaxoSmithKline Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Merck Corporate Information, Head Office, and Major Competitors
Table 47. Merck Major Business
Table 48. Merck Biopharmaceutical and Vaccines Product and Solutions
Table 49. Merck Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Lonza Corporate Information, Head Office, and Major Competitors
Table 51. Lonza Major Business
Table 52. Lonza Biopharmaceutical and Vaccines Product and Solutions
Table 53. Lonza Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 55. Boehringer Ingelheim Major Business
Table 56. Boehringer Ingelheim Biopharmaceutical and Vaccines Product and Solutions
Table 57. Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Rentschler Corporate Information, Head Office, and Major Competitors
Table 59. Rentschler Major Business
Table 60. Rentschler Biopharmaceutical and Vaccines Product and Solutions
Table 61. Rentschler Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Biopharmaceutical and Vaccines Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Biopharmaceutical and Vaccines Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Biopharmaceutical and Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Biopharmaceutical and Vaccines Players Head Office, Products and Services Provided
Table 66. Biopharmaceutical and Vaccines Mergers & Acquisitions in the Past Five Years
Table 67. Biopharmaceutical and Vaccines New Entrants and Expansion Plans
Table 68. Global Biopharmaceutical and Vaccines Revenue (USD Million) by Type (2017-2022)
Table 69. Global Biopharmaceutical and Vaccines Revenue Share by Type (2017-2022)
Table 70. Global Biopharmaceutical and Vaccines Revenue Forecast by Type (2023-2028)
Table 71. Global Biopharmaceutical and Vaccines Revenue by Application (2017-2022)
Table 72. Global Biopharmaceutical and Vaccines Revenue Forecast by Application (2023-2028)
Table 73. North America Biopharmaceutical and Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Biopharmaceutical and Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Biopharmaceutical and Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Biopharmaceutical and Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Biopharmaceutical and Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Biopharmaceutical and Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Biopharmaceutical and Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Biopharmaceutical and Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Biopharmaceutical and Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Biopharmaceutical and Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Biopharmaceutical and Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Biopharmaceutical and Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Biopharmaceutical and Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Biopharmaceutical and Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Biopharmaceutical and Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Biopharmaceutical and Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Biopharmaceutical and Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Biopharmaceutical and Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Biopharmaceutical and Vaccines Picture
Figure 2. Global Biopharmaceutical and Vaccines Revenue Market Share by Type in 2021
Figure 3. Biopharmaceutical
Figure 4. Vaccine Production
Figure 5. Biopharmaceutical and Vaccines Revenue Market Share by Application in 2021
Figure 6. Pharmaceuticals Industry Picture
Figure 7. Clinical Diagnosis Picture
Figure 8. Scientific Research Picture
Figure 9. Others Picture
Figure 10. Global Biopharmaceutical and Vaccines Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Biopharmaceutical and Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Biopharmaceutical and Vaccines Revenue Market Share by Region (2017-2028)
Figure 13. Global Biopharmaceutical and Vaccines Revenue Market Share by Region in 2021
Figure 14. North America Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Biopharmaceutical and Vaccines Market Drivers
Figure 20. Biopharmaceutical and Vaccines Market Restraints
Figure 21. Biopharmaceutical and Vaccines Market Trends
Figure 22. Novartis Recent Developments and Future Plans
Figure 23. Pfizer Recent Developments and Future Plans
Figure 24. Sanofi Recent Developments and Future Plans
Figure 25. Roche Recent Developments and Future Plans
Figure 26. Abbott Recent Developments and Future Plans
Figure 27. Biogen Idec Recent Developments and Future Plans
Figure 28. Regeneron Pharmaceuticals Recent Developments and Future Plans
Figure 29. Alexion Pharmaceuticals Recent Developments and Future Plans
Figure 30. Johnson and Johnson Recent Developments and Future Plans
Figure 31. GlaxoSmithKline Recent Developments and Future Plans
Figure 32. Merck Recent Developments and Future Plans
Figure 33. Lonza Recent Developments and Future Plans
Figure 34. Boehringer Ingelheim Recent Developments and Future Plans
Figure 35. Rentschler Recent Developments and Future Plans
Figure 36. Global Biopharmaceutical and Vaccines Revenue Share by Players in 2021
Figure 37. Biopharmaceutical and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 38. Global Top 3 Players Biopharmaceutical and Vaccines Revenue Market Share in 2021
Figure 39. Global Top 10 Players Biopharmaceutical and Vaccines Revenue Market Share in 2021
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 41. Global Biopharmaceutical and Vaccines Revenue Share by Type in 2021
Figure 42. Global Biopharmaceutical and Vaccines Market Share Forecast by Type (2023-2028)
Figure 43. Global Biopharmaceutical and Vaccines Revenue Share by Application in 2021
Figure 44. Global Biopharmaceutical and Vaccines Market Share Forecast by Application (2023-2028)
Figure 45. North America Biopharmaceutical and Vaccines Sales Market Share by Type (2017-2028)
Figure 46. North America Biopharmaceutical and Vaccines Sales Market Share by Application (2017-2028)
Figure 47. North America Biopharmaceutical and Vaccines Revenue Market Share by Country (2017-2028)
Figure 48. United States Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe Biopharmaceutical and Vaccines Sales Market Share by Type (2017-2028)
Figure 52. Europe Biopharmaceutical and Vaccines Sales Market Share by Application (2017-2028)
Figure 53. Europe Biopharmaceutical and Vaccines Revenue Market Share by Country (2017-2028)
Figure 54. Germany Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Biopharmaceutical and Vaccines Sales Market Share by Type (2017-2028)
Figure 60. Asia-Pacific Biopharmaceutical and Vaccines Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Biopharmaceutical and Vaccines Revenue Market Share by Region (2017-2028)
Figure 62. China Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South Korea Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Biopharmaceutical and Vaccines Sales Market Share by Type (2017-2028)
Figure 69. South America Biopharmaceutical and Vaccines Sales Market Share by Application (2017-2028)
Figure 70. South America Biopharmaceutical and Vaccines Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East and Africa Biopharmaceutical and Vaccines Sales Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Biopharmaceutical and Vaccines Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Biopharmaceutical and Vaccines Revenue Market Share by Country (2017-2028)
Figure 76. Turkey Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. UAE Biopharmaceutical and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
